Search results for "Titi"

showing 10 items of 6322 documents

Photobiomodulation therapy for the management of recurrent aphthous stomatitis in children : clinical effectiveness and parental satisfaction

2020

Background This study aims to evaluate the effectiveness of the photobiomodulation therapy (PBMT) in the treatment of minor recurrent aphthous stomatitis (MiRAS) in children, in terms of pain relief, lesion size reduction and the parental satisfaction of the therapy. Material and Methods This randomized controlled study was carried out on 60 children with clinical diagnosis of MiRAS. Patients were randomized into two groups: group A receiving laser therapy and group B receiving sham therapy (placebo). Laser therapy (diode laser, λ: 645 nm) was administered on day 1 (T0) for three consecutive days. Patients were evaluated also on day 4 (T1), on day 7 (T2) and on day 10 (T3). Oral aphthous le…

medicine.medical_specialtyVisual analogue scaleChildren; Lasers; UlcersPersonal SatisfactionPlaceboRecurrent aphthous stomatitisPeriodontal probeGroup Blaw.inventionLesion03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicinemedicineHumansLow-Level Light TherapyChildChildrenGeneral DentistryStomatitisPain MeasurementUlcersOral Medicine and Pathologybusiness.industryResearchLasers030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Treatment OutcomeOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASStomatitis AphthousSurgerymedicine.symptombusiness
researchProduct

Local Formula with Mucoadhesive Property: A Randomized Clinical Trial of a Therapeutic Agent for the Treatment of Oral Aphthous Ulcers

2020

Background Recurrent or occasional aphthous lesions represent a painful oral condition with high prevalence. Since the etiology is still unclear and most likely related to a dysfunction in the local immune system, several treatment strategies have been proposed, including systemic agents, local agents, and laser therapy, to reduce the pain and discomfort for the patient without acting on the causes. Materials and methods The purpose of the present randomized study was to assess the clinical efficacy of a new topical gel with mucoadhesive property to reduce the pain and the dimension of the aphthosis lesions. Fifty patients presenting at least one minor ulcer were randomized to a control gro…

medicine.medical_specialtyVisual analogue scalePainPlacebolaw.invention03 medical and health sciencesOral aphthous ulcers0302 clinical medicineRandomized controlled triallawAdjuvant therapyHumansMedicineClinical significanceMedical prescriptionGeneral DentistryWound Healingbusiness.industry030206 dentistryDermatologyTreatment Outcome030220 oncology & carcinogenesisEtiologyStomatitis AphthousbusinessGelsThe Journal of Contemporary Dental Practice
researchProduct

Treatment of chronic hepatitis C in hemodialysis patients

2008

Hepatitis C virus (HCV) infection is especially problematic in patients with end-stage renal disease (ESRD) who are undergoing hemodialysis. Rates of HCV infection are higher among hemodialysis patients than in the general population, and several routes of transmission are thought to stem from the dialysis unit. Management of chronic hepatitis C is also more complicated in hemodialysis patients because of altered pharmacokinetics and a predisposition for drug-related toxicity, particularly ribavirin-induced anemia. Clinical trials of patients with chronic hepatitis C and healthy, functioning kidney grafts are rare because of the inherent dangers of graft rejection. As a result, most studies…

medicine.medical_specialtyWaiting ListsHepatitis C virusmedicine.medical_treatmentPopulationInterferon alpha-2medicine.disease_causeAntiviral AgentsPolyethylene Glycolschemistry.chemical_compoundRenal DialysisInternal medicinePrevalencemedicineHumanseducationInterferon alfaeducation.field_of_studyHepatologybusiness.industryRibavirinInterferon-alphavirus diseasesHepatitis CHepatitis C ChronicHepatologymedicine.diseaseKidney TransplantationRecombinant Proteinsdigestive system diseasesSurgeryTolerabilitychemistryKidney Failure ChronicHemodialysisbusinessmedicine.drugHepatology
researchProduct

Selected peptides targeted to the NMDA receptor channel protect neurons from excitotoxic death

1998

Excitotoxic neuronal death, associated with neurodegeneration and stroke, is triggered primarily by massive Ca2+ influx arising from overactivation of glutamate receptor channels of the N-methyl-D-aspartate (NMDA) subtype. To search for channel blockers, synthetic combinatorial libraries were assayed for block of agonist-evoked currents by the human NR1-NR2A NMDA receptor subunits expressed in amphibian oocytes. A set of arginine-rich hexapeptides selectively blocked the NMDA receptor channel with IC50 approximately 100 nM, a potency similar to clinically tolerated blockers such as memantine, and only marginally blocked on non-NMDA glutamate receptors. These peptides prevent neuronal cell d…

medicine.medical_specialtyXenopusDrug Evaluation PreclinicalBiomedical EngineeringBioengineeringHippocampal formationBiologyPharmacologyArginineBinding CompetitiveHippocampusReceptors N-Methyl-D-AspartateApplied Microbiology and BiotechnologySubstrate SpecificityInternal medicinemedicineAnimalsHumansChannel blockerReceptorNeuronsCell DeathNeurodegenerationGlutamate receptorMemantinemedicine.diseaseRatsEndocrinologymedicine.anatomical_structurenervous systemDrug DesignOocytesMolecular MedicineNMDA receptorFemaleNeuronPeptidesBiotechnologymedicine.drugNature Biotechnology
researchProduct

Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation o…

2013

Abstract Biomarker-guided initiation of antibiotic therapy has been studied in four conditions: acute pancreatitis, lower respiratory tract infection (LRTI), meningitis, and sepsis in the ICU. In pancreatitis with suspected infected necrosis, initiating antibiotics best relies on fine-needle aspiration and demonstration of infected material. We suggest that PCT be measured to help predict infection; however, available data are insufficient to decide on initiating antibiotics based on PCT levels. In adult patients suspected of community-acquired LRTI, we suggest withholding antibiotic therapy when the serum PCT level is low (<0.25 ng/mL); in patients having nosocomial LRTI, data are insuf…

medicine.medical_specialty[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]medicine.drug_class[SHS.INFO]Humanities and Social Sciences/Library and information sciencesAntibioticsReviewpneumonia;meningitis;pancreatitis;infection;sepsis;emergency medicine;biomarkers;procalcitonin;C-reactive proteinCritical Care and Intensive Care Medicine[SHS.INFO] Humanities and Social Sciences/Library and information sciencesProcalcitoninC-reactive proteinSepsis03 medical and health sciences0302 clinical medicineLower respiratory tract infectionSepsismedicine[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO][ SHS.INFO ] Humanities and Social Sciences/Library and information sciencesMeningitis030212 general & internal medicineIntensive care medicine: Infectionddc:6160303 health sciences030306 microbiologybusiness.industry[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Pneumoniamedicine.disease3. Good healthDiscontinuationPneumoniaPancreatitisPancreatitisEmergency medicineInfectionbusinessMeningitisProcalcitoninBiomarkersAnnals of Intensive Care
researchProduct

Effects of High Frequency Repetitive Transcranial Magnetic Stimulation (HF-rTMS) on Delay Discounting in Major Depressive Disorder: An Open-Label Unc…

2019

Background: Delay discounting (DD) refers to the decrease of a present subjective value of a future reward as the delay of its delivery increases. Major depressive disorder (MDD), besides core emotional and physical symptoms, involves difficulties in reward processing. Depressed patients often display greater temporal discounting rates than healthy subjects. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique applied in several countries to adult patients with treatment resistant depression. Studies suggest that this technique can be used to modulate DD, but no trial has assessed its effects on depressed patients. Methods: In this open-label unc…

medicine.medical_specialty[SDV]Life Sciences [q-bio]medicine.medical_treatmentimpulsivityAudiologyImpulsivitybehavioral disciplines and activitiesArticlelcsh:RC321-57103 medical and health sciences0302 clinical medicinemental disordersmedicineTemporal discountinglcsh:Neurosciences. Biological psychiatry. Neuropsychiatrydelay discountingmajor depressive disorderbusiness.industryGeneral Neurosciencerepetitive transcranial magnetic stimulationhigh frequency repetitive transcranial magnetic stimulationCognitionmedicine.disease030227 psychiatry3. Good healthDorsolateral prefrontal cortexTranscranial magnetic stimulationmedicine.anatomical_structure[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthBrain stimulationMajor depressive disordermedicine.symptombusinessTreatment-resistant depression030217 neurology & neurosurgeryBrain Sciences
researchProduct

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course

2019

Antisynthetase syndrome (ASSD) is a rare clinical condition that is characterized by the occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung disease (ILD), along with specific autoantibodies that are addressed to different aminoacyl tRNA synthetases (ARS). Until now, it has been unknown whether the presence of a different ARS might affect the clinical presentation, evolution, and outcome of ASSD. In this study, we retrospectively recorded the time of onset, characteristics, clustering of triad findings, and survival of 828 ASSD patients (593 anti-Jo1, 95 anti-PL7, 84 anti-PL12, 38 anti-EJ, and 18 anti-OJ), referring to AENEAS (American and Europea…

medicine.medical_specialtyantisynthetase antibodies; antisynthetase syndrome; arthritis; interstitial lung disease; myositisantisynthetase syndrome; antisynthetase antibodies; arthritis; myositis; interstitial lung diseaseMedizinArthritislcsh:MedicineAntisynthetase syndromeInterstitial lung diseaseAntisynthetase syndromeArticleNO03 medical and health sciences0302 clinical medicineInternal medicinemedicineantisynthetase antibodiesantisynthetase antibodies antisynthetase syndrome arthritis interstitial lung disease myositisddc:610Myositis030203 arthritis & rheumatologyinterstitial lung diseaseAntisynthetase antibodiesbiologyMyositisbusiness.industryArthritislcsh:RInterstitial lung diseaseAutoantibodyGeneral Medicinemedicine.diseasearthriti030228 respiratory systemarthritisTime courseCohortbiology.proteinAntibodyantisynthetase syndromebusinessantisynthetase antibodiemyositis
researchProduct

Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentratio…

2015

Background: OMA is an effective treatment option in SAA. However, little data are available on the long-term-efficacy oft the drug. Objective: To determine the long-term efficacy of OMA in respect to clinical parameters and IgE serum levels. Methods: This was a retrospective, open-label, uncontrolled, multi-center observational study according to the definition of non-interventional studies. 22 non-smoking patients (10 m, 12 f; mean age 47,9 yrs) with SAA were enrolled. Pat were treated with OMA up to for 4 years and total serum IgE levels were assessed at initiation of therapy, after 2-6 ms and 3-5 yrs. Data were recorded on standardized CRFs by the treating physician. Results: The average…

medicine.medical_specialtybiologybusiness.industryAllergic asthmaAtopic dermatitisOmalizumabImmunoglobulin Emedicine.diseaseGastroenterologyTreatment periodSerum igeFood allergyInternal medicineConcomitantImmunologybiology.proteinmedicinebusinessmedicine.drug5.3 Allergy and Immunology
researchProduct

Stellenwert des Tumormarkers CA 19–9 in der Differentialdiagnose von Raumforderungen im Pankreaskopf

1996

In 96 patients (ductal pancreatic carcinoma, n = 34; periampullary carcinoma, n = 43; chronic pancreatitis, n = 19) the role of CA 19-9 in the diagnosis of lesions of the head of the pancreas were evaluated. The sensitivity for ductal pancreatic carcinoma was 73.3%, for periampullary carcinoma 48.8%, and specificity was 63.2%. Carcinoembryonic antigen was elevated only in every fifth patient. Even when combining the two tumor markers no increase in sensitivity could be observed. The low specificity of 63%, which decreased to 33% in the case of obstructive jaundice, does not allow adequate preoperative differentiation between cancer patients and those with chronic pancreatitis. In cases of p…

medicine.medical_specialtybiologybusiness.industryCancermedicine.diseaseGastroenterologyCarcinoembryonic antigenmedicine.anatomical_structureInternal medicinemedicinebiology.proteinCarcinomaPancreatitisSurgeryCA19-9Differential diagnosisPancreasbusinessTumor markerDer Chirurg
researchProduct

Chronic Prostatitis Syndrome: A Common, but Poorly Understood Condition. Part I

2007

Abstract Chronic Prostatitis Syndrome (CPS) is a frequent disease. Before the PSA era, data from various sources showed that there were more outpatient visits for CPS than for BPH or prostate cancer. CPS has a very negative impact on the patients’ quality of life. However, this debilitating disease stimulates relatively little enthusiasm in the urological world. The classification proposed by the National Institutes of Health is widely adopted. The disease is described as “Chronic Prostatitis/Chronic Pelvic Pain Syndrome” and considers four categories. Category III includes Chronic Inflammatory Prostatitis and Prostatodynia. Universally accepted guidelines for diagnostic work-up are not ava…

medicine.medical_specialtybiologybusiness.industryUrologyPelvic painInterstitial cystitisProstatitisDiseasemedicine.diseasebiology.organism_classificationUreaplasmaChronic bacterial prostatitisEpidemiologymedicineEtiologyPhysical therapymedicine.symptomIntensive care medicinebusinessEAU-EBU Update Series
researchProduct